| HGNC Family | Non-coding RNAs |
| Name | microRNA 100 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have demonstrated that MIR100—which encodes microRNA‐100—plays critical roles in intercellular communication and therapeutic response. In several tumor models including breast, colorectal, lung, and pancreatic cancers, MIR100 is transferred via exosomes or coordinately induced as part of a long non‐coding host transcript (MIR100HG) in response to TGF‐β signaling. Such RNA‐mediated intercellular transfer modulates cell cycle distribution and drug‐induced apoptosis, thereby contributing to acquired chemoresistance and a more aggressive tumor phenotype."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFunctionally, MIR100 predominantly exerts tumor‐suppressive effects in a range of solid tumors by post‐transcriptionally regulating key oncogenic pathways. Restoration of MIR100 expression suppresses cell proliferation, promotes apoptosis, and impairs migration and invasion—thereby improving sensitivity to cytotoxic agents. These outcomes are largely mediated through direct targeting of molecules such as mTOR, Polo‐like kinase 1 (PLK1), insulin‐like growth factor receptors, HOXA1, BMPR2, and components of the Wnt/β‐catenin pathway, resulting in alterations in cell cycle progression and diminished tumor aggressiveness. In diverse cancers including prostate, ovarian, hepatocellular, and lung carcinomas, decreased MIR100 levels have been correlated with advanced stage disease and poorer clinical outcome."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its direct effects on tumor cell proliferation and survival, MIR100 is implicated in the regulation of cancer stem cell self‐renewal, differentiation, and metastatic spread. Embedded within MIR100HG transcripts, its biogenesis is subject to additional layers of regulation via competing endogenous RNAs—such as circular RNAs and long non‐coding RNAs—that sequester MIR100 and modulate its availability. Furthermore, alterations in circulating MIR100 levels have shown promise as non‐invasive biomarkers for early diagnosis and for prognostic stratification in several malignancies (e.g., gastric, bladder and pediatric cancers) as well as in non‐malignant contexts like wound healing and inflammatory injury. These multifaceted roles underscore MIR100’s potential as both a mechanistic target and a biomarker in cancer management."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "43"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wei-xian Chen, Xue-min Liu, Meng-meng Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0095240"}], "href": "https://doi.org/10.1371/journal.pone.0095240"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24740415"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24740415"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xiaobing Qin, Shaorong Yu, Leilei Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Nanomedicine (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/IJN.S131516"}], "href": "https://doi.org/10.2147/IJN.S131516"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28553110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28553110"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yuanyuan Lu, Xiaodi Zhao, Qi Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.4424"}], "href": "https://doi.org/10.1038/nm.4424"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29035371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29035371"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Silvia Ottaviani, Justin Stebbing, Adam E Frampton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-03962-x"}], "href": "https://doi.org/10.1038/s41467-018-03962-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29748571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29748571"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wei Shi, Nehad M Alajez, Carlo Bastianutto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24880"}], "href": "https://doi.org/10.1002/ijc.24880"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19739117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19739117"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Ankur K Nagaraja, Chad J Creighton, Zhifeng Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2009-0295"}], "href": "https://doi.org/10.1210/me.2009-0295"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20081105"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20081105"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "V Boni, R Zarate, J C Villa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tpj.2010.58"}], "href": "https://doi.org/10.1038/tpj.2010.58"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20585341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20585341"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wooi Loon Ng, Dan Yan, Xiangming Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Repair (Amst) (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.dnarep.2010.08.007"}], "href": "https://doi.org/10.1016/j.dnarep.2010.08.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20869334"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20869334"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Dandan Sun, Yong Sun Lee, Ankit Malhotra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-1031"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-1031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21212412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21212412"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Y-S Zheng, H Zhang, X-J Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.208"}], "href": "https://doi.org/10.1038/onc.2011.208"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21643017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21643017"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bing Feng, Rui Wang, Long-Bang Chen "}, {"type": "b", "children": [{"type": "t", "text": "MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2011.11.024"}], "href": "https://doi.org/10.1016/j.canlet.2011.11.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22120675"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22120675"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Dong-Xian Peng, Min Luo, Li-Wen Qiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2012.1625"}], "href": "https://doi.org/10.3892/or.2012.1625"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22246341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22246341"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "A Petrelli, A Perra, K Schernhuber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.631"}], "href": "https://doi.org/10.1038/onc.2011.631"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22249248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22249248"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yang Zeng, Xuebin Qu, Hongling Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2012.05.049"}], "href": "https://doi.org/10.1016/j.febslet.2012.05.049"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22684006"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22684006"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Anna Torres, Kamil Torres, Anna Pesci, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-12-369"}], "href": "https://doi.org/10.1186/1471-2407-12-369"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22920721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22920721"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "C A Gebeshuber, J Martinez "}, {"type": "b", "children": [{"type": "t", "text": "miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.372"}], "href": "https://doi.org/10.1038/onc.2012.372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22926517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22926517"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Angeline A Giangreco, Avani Vaishnav, Dennis Wagner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Prev Res (Phila) (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1940-6207.CAPR-12-0253"}], "href": "https://doi.org/10.1158/1940-6207.CAPR-12-0253"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23503652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23503652"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dahu Chen, Yutong Sun, Yuan Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1004177"}], "href": "https://doi.org/10.1371/journal.pgen.1004177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24586203"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24586203"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yi-Yuan Ge, Qing Shi, Zhi-Yuan Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.2189"}], "href": "https://doi.org/10.18632/oncotarget.2189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25026290"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25026290"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yi Gong, Tianliang He, Lu Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of miR-100 in regulating apoptosis of breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep11650"}], "href": "https://doi.org/10.1038/srep11650"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26130569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26130569"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Qian Jiang, Miao He, Shu Guan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4342-x"}], "href": "https://doi.org/10.1007/s13277-015-4342-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26537584"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26537584"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Baotong Zhang, Ranran Zhao, Yuan He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6790"}], "href": "https://doi.org/10.18632/oncotarget.6790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26744318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26744318"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jessica Clague, Scott M Lippman, Hushan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in MicroRNA genes and risk of oral premalignant lesions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.20588"}], "href": "https://doi.org/10.1002/mc.20588"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19851984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19851984"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Bao Hua Li, Jian Song Zhou, Feng Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejca.2011.04.037"}], "href": "https://doi.org/10.1016/j.ejca.2011.04.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21636267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21636267"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Dawoon E Jung, Jing Wen, Taeyun Oh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differentially expressed microRNAs in pancreatic cancer stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreas (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MPA.0b013e318221b33e"}], "href": "https://doi.org/10.1097/MPA.0b013e318221b33e"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21785383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21785383"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Jaqueline Carvalho de Oliveira, Carlos Alberto Scrideli, María Sol Brassesco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2011.10.005"}], "href": "https://doi.org/10.1016/j.leukres.2011.10.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22099053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22099053"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yi Jin, Stéphanie D Tymen, Dan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0064434"}], "href": "https://doi.org/10.1371/journal.pone.0064434"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23724047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23724047"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "F Akbari Moqadam, E A M Lange-Turenhout, I M Ariës, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2013.06.027"}], "href": "https://doi.org/10.1016/j.leukres.2013.06.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23915977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23915977"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "X-J Li, X-Q Luo, B-W Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2013.562"}], "href": "https://doi.org/10.1038/bjc.2013.562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24030073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24030073"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Faman Xiao, Yifeng Bai, Zhenzhu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejca.2014.01.024"}], "href": "https://doi.org/10.1016/j.ejca.2014.01.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24559685"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24559685"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Min Wang, Dong Ren, Wei Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2014.2413"}], "href": "https://doi.org/10.3892/ijo.2014.2413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24805183"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24805183"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Lu Deng, Li Shang, Shoumin Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-3710"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-3710"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25217527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25217527"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Hui Wang, Lei Wang, Zheng Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-014-0298-8"}], "href": "https://doi.org/10.1007/s12032-014-0298-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25367852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25367852"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Chu Qin, Ru-Yi Huang, Zhao-Xia Wang "}, {"type": "b", "children": [{"type": "t", "text": "Potential role of miR-100 in cancer diagnosis, prognosis, and therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3267-8"}], "href": "https://doi.org/10.1007/s13277-015-3267-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25740059"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25740059"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Johannes Denk, Kai Boelmans, Christine Siegismund, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0126423"}], "href": "https://doi.org/10.1371/journal.pone.0126423"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25992776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25992776"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Chen Li, Yanping Gao, Kai Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000438572"}], "href": "https://doi.org/10.1159/000438572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26606597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26606597"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6599"}], "href": "https://doi.org/10.18632/oncotarget.6599"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26684239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26684239"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Tarek Kamal Motawi, Sherine Maher Rizk, Taghreed Mahmoud Ibrahim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Funct (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbf.3171"}], "href": "https://doi.org/10.1002/cbf.3171"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26916216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26916216"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Hui-Chao Zhou, Jian-Hong Fang, Li-Ru Shang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4804"}], "href": "https://doi.org/10.1002/path.4804"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27577856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27577856"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Katayoon Pakravan, Sadegh Babashah, Majid Sadeghizadeh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-017-0335-7"}], "href": "https://doi.org/10.1007/s13402-017-0335-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28741069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28741069"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Meihan Liu, Tao Han, Shaomin Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HAGLROS regulates cell apoptosis and autophagy in lipopolysaccharides-induced WI-38 cells via modulating miR-100/NF-κB axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.04.109"}], "href": "https://doi.org/10.1016/j.bbrc.2018.04.109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29673591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29673591"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Qinyu Sun, Vidisha Tripathi, Je-Hyun Yoon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gky696"}], "href": "https://doi.org/10.1093/nar/gky696"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30102375"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30102375"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Yijun Shi, Zizhang Guo, Na Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "hsa_circ_0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109151"}], "href": "https://doi.org/10.1016/j.biopha.2019.109151"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31229921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31229921"}]}]}]}
|
| Synonyms | MIR-100, MIRN100 |
| NCBI Gene ID | 406892 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR100 has 876 functional associations with biological entities spanning 5 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 22 datasets.
Click the + buttons to view associations for MIR100 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR100 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR100 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR100 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MIR100 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR100 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR100 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MIR100 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR100 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR100 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR100 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GAD Gene-Disease Associations | diseases associated with MIR100 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR100 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR100 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR100 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MIR100 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MIR100 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR100 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR100 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR100 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR100 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MIR100 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR100 protein from the Wikipathways Pathways 2014 dataset. | |